Synergistic effect of magnetic nanoparticles of Fe3O4 with gambogic acid on apoptosis of K562 leukemia cells by Chen, Baoan et al.
© 2009 Chen et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine
International Journal of Nanomedicine 2009:4 251–259 251
Dovepress
open access to scientific and medical research
Open Access Full Text Article
submit your manuscript | www.dovepress.com
Dovepress 
O R I g I N A L   R e s e A R C h
synergistic effect of magnetic nanoparticles  
of Fe3O4 with gambogic acid on apoptosis  
of K562 leukemia cells
Baoan Chen1,* 
Yiqiong Liang1,* 
Weiwei Wu1 
Jian Cheng1 
guohua Xia1 
Feng gao1 
Jiahua Ding1 
Chong gao1 
Zeye shao1 
guohong Li1 
Wenji Chen1 
Wenlin Xu2 
Xinchen sun3 
Lijie Liu4 
Xiaomao Li5 
Xuemei Wang6
1Department of hematology; 
3Department of Oncology,   The 
Affiliated Zhongda hospital, Clinical 
Medical school, southeast University, 
Nanjing, People’s Republic of China; 
2Department of hematology,   The 
Affiliated People’s hospital, Jiangsu 
University, Zhenjiang, People’s Republic 
of China; 4Institution of Physiology, 
southeast University, Nanjing, People’s 
Republic of China; 5Department 
of Physics, University of saarland, 
saarbruechen, germany; 6state Key 
Lab of Bioelectronics (Chien-shiung 
Wu Laboratory), southeast University, 
Nanjing, Peoples Republic of China; 
*These authors have contributed 
equally to this work
Correspondence: Baoan Chen 
Department of Hematology,   The affiliated 
Zhongda hospital, southeast University, 
Nanjing 210009, People’s Republic of 
China 
Tel +86 25 8327 2006 
Fax +86 25 8327 2011 
email cba8888@hotmail.com
Abstract: Gambogic acid (GA) has a significant anticancer effect on a wide variety of solid 
tumors. Recently, many nanoparticles have been introduced as drug-delivery systems to enhance 
the efficiency of anticancer drug delivery. The aim of this study was to investigate the potential 
benefit of combination therapy with GA and magnetic nanoparticles of Fe3O4 (MNPs-Fe3O4). The 
proliferation of K562 cells and their cytotoxicity were evaluated by MTT assay. Cell apoptosis 
was observed and analyzed by microscope and flow cytometry, respectively. Furthermore, real-
time polymerase chain reaction and Western blotting analyses were performed to examine gene 
transcription and protein expression, respectively. The results showed that MNPs-Fe3O4 dramati-
cally enhanced GA-induced cytotoxicity and apoptosis in K562 cells. The typical morphological 
features of apoptosis treated with GA and MNPs-Fe3O4 were observed under an optical micro-
scope and a fluorescence microscope, respectively. The transcription of caspase-3 and bax gene 
in the group treated with GA and MNPs-Fe3O4 was higher than that in the GA-alone group or 
MNPs-Fe3O4-alone group, but the transcription of bcl-2, nuclear factor-κB, and survivin degraded 
as did the expression of corresponding proteins in K562 cells. Our data suggests a potential 
clinical application of a combination of GA and MNPs-Fe3O4 in leukemia therapy.
Keywords: gambogic acid, magnetic nanoparticles of Fe3O4, traditional Chinese medicine, 
K562 leukemia cells, apoptosis
Introduction
A major problem of cancer therapy is the side effects of chemotherapy. Minimizing side 
effects and maximizing efficacy is a major goal in the development of tumor treatment.1 
Gambogic acid (GA), a naturally occurring brownish orange resin called gamboge,2 
possesses diverse biological effects such as anti-inflammatory and antioxidant actions.3 
Recent studies showed that GA could inhibit the growth of a wide variety of tumor 
cells, including hepatoma, pulmonary carcinoma, gastric cancer, and breast cancer 
cells.4–14 How GA mediates the growth of these tumor cells is not fully understood, 
but GA has been shown to induce apoptosis, arrest cell cycles, and downregulate bcl-2 
and telomerase activity.14,15 Preclinical research revealed that a therapeutic dose of GA 
did not inhibit the proliferation of bone marrow, peripheral blood leucocyte count, or 
phagocytotic function of macrophage in tumor-bearing mice.16 Because of its broad 
spectrum anticancer actions, satisfactory therapeutic effect, and good tolerance, GA 
is a promising candidate in anticancer drugs.
Another key problem for tumor treatment is the reducing sensitivity of tumor cells 
to cytotoxic drugs. Thus, many polymer nanospheres and nanoparticles have been 
introduced as drug-delivery systems to enhance the efficiency of anticancer drug International Journal of Nanomedicine 2009:4 252
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delivery based on the ability to target specific locations in the 
body.17 The most promising materials are magnetic nanopar-
ticles. Magnetic nanoparticles of Fe3O4 (MNPs-Fe3O4), 
a biocompatible and superparamagnetic nanomaterial with 
satisfactory chemical stability and low toxicity, are widely 
used for targeted-drug carriers with target-orientation and 
sustained-release properties.18
Our study aims to evaluate the potential benefit of com-
bination therapy with GA and MNPs-Fe3O4 for leukemia and 
whether MNPs-Fe3O4 could promote the apoptosis induced 
by GA. To elucidate the mechanisms possibly involved, we also 
measured the expression of apoptosis-related genes and pro-
teins, including caspase-3, bax, bcl-2, NF-κB, and survivin.
Materials and methods
Main reagents
GA (Kanion Pharmaceutical Co., Ltd, Jiangsu, China) was 
dissolved in dimethyl sulfoxide (DMSO; Sigma Aldrich, St. 
Louis, MO), stored at -20 °C, and then diluted as needed 
in RPMI 1640 medium (Gibco/BRL, Carlsbad, CA). MTT 
was purchased from Sigma Aldrich. Monoclonal antibodies 
including caspase-3, bax, bcl-2, NF-κB, survivin, and β-actin 
were purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA). MNPs-Fe3O4 (State Key Lab of Bioelectronics, 
Nanjing, China) were well distributed in RPMI 1640 medium 
containing 10% (v/v) heat-inactivated new-born calf serum 
(Sijiqing, Hangzhou, China) by using ultrasound treatment 
in order to obtain MNPs-Fe3O4 colloidal suspension. GA 
conjugated with MNPs-Fe3O4 was prepared by mechanical 
absorption polymerization at 4 °C for 48 hours.
Cell lines and culture conditions
K562 cells, derived from human leukemic cells from a 
chronic myeloid leukemia patient in blastic crisis and con-
stantly preserved in our laboratory, were cultured in RPMI 
1640 medium containing 10% (v/v) heat-inactivated fetal calf 
serum, 100 U/mL penicillin, and 100 µg/mL streptomycin at 
37 °C in a humidified 5% CO2 incubator.
Cell viability assay
Cytotoxicity was determined by the MTT assay. K562 cells 
(8 × 103/mL) were incubated into 96-well flat-bottomed 
plates (Costar, Charlotte, NC). Different concentrations 
of GA were added into these cells and cultured at 37 °C 
for 24, 48, and 72 hours, respectively. To determine the 
optimum synergistic effect of MNPs-Fe3O4, different 
concentrations of MNPs-Fe3O4 were used symphysially 
with or without GA in graded concentrations. Briefly, 20 µL 
MTT (5 mg/mL) was added to each well and incubated 
at 37 °C for 4 hours. The formazan was dissolved with 
150 µL dimethyl sulfoxide (Sigma Aldrich) and the reduc-
tion of MTT was quantified by absorbance at 570 nm using 
a plate reader (Model 550; Bio-Rad Laboratories, Tokyo, 
Japan). The inhibition ratio (IR) of cells was determined 
as follows: (1-Atreated group/Acontrol group) × 100%. The 50% 
inhibiting concentration (IC50) was defined as the concentra-
tion required for 50% inhibition of cell growth.
Apoptosis assay by flow cytometer
Quantification of apoptotic cells was performed using an 
Annexin-V-FITC Apoptosis Detection Kit (KenGen, Nanjing, 
China) according to the manufacturer’s instructions. After 
incubation in a medium containing different drugs at 37 °C for 
48 hours, the cells were collected and suspended in 500 µL of 
binding buffer, and 5 µL Annexin-V-fluorescein isothiocyanate 
(FITC) and 5 µL propidium iodide (PI) were added at room 
temperature in the dark for 15 minutes. Analyses were 
performed by FACScan flow cytometer (Becton Dickinson, 
Sunnyvale, CA). The cells in the FITC-positive and PI-negative 
fraction were regarded as apoptotic cells.
Cell morphological assessment
After being cultured in RPMI-1640 containing 6 mg/L GA, 
0.6 mg/L GA conjugated with 10 mg/L MNPs-Fe3O4 or 
without GA at 37 °C for 48 hours, K562 cells were collected 
and smeared. Some films were stained with Wright’s stain 
to observe the morphological changes of apoptosis cells by 
optical microscope; others were fixed with methanol for 
15 minutes, stained with fluorochrome dye DAPI (Santa Cruz 
Biotechnologies), and then observed under a fluorescence 
microscope (IX51; Olympus, Tokyo, Japan) with a peak 
excitation wave length of 340 nm.
Quantitative real-time PCR  
(QPCR) analysis
As described before, K562 cells (8 × 103/mL) were treated, 
harvested, and then total RNA was isolated using Trizol 
reagent (Invitrogen Life Technologies, Carlsbad, CA) 
according to the manufacturer’s protocol. The reverse tran-
scription reactions were performed using SuperScript™ 
II reverse transcriptase (Invitrogen Life Technologies) and 
the newly synthetic cDNA was amplified within target 
and control sequences (primer sequences for caspase-3 
(270 bp) forward, 5′-GCTATTGTGAGGCGGTTGT-3′ 
and reverse, 5′-TGTTTCCCTGAGGTTTGC-3′; Bax 
(114 bp) forward, 5′-TTTTGCTTCAGGGTTTCATC-3′ International Journal of Nanomedicine 2009:4 253
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and reverse, 5′-GACACTCGCTCAGCTTCTTG-3′; Bcl-2 
(452 bp) forward, 5′-GGGAGAACAGGGTACGATAA-3′ 
and reverse, 5′-CCACCGAACTCAAAGAAGG-3′; NF-κB 
(227 bp) forward, 5′-TCGTTTCCGTT ATGTATGT-3′ and 
reverse, 5′-CCTTGGGTCCAGCAGTTA-3′; Survivin 
(255 bp) forward, 5′-CAAGGACCACCGCATCTC-3′ 
and reverse, 5′-CCAAGGGTTAATTCTTCAAACT-3′; 
GAPDH (205 bp) forward, 5′-CGGATTTGGTCGTATTG-3′ 
and reverse, 5′-GAAGATGGTGATGGGATT-3′). QPCR 
was performed by monitoring in real-time the increase of 
fluorescence of SYBR green I dye (Takara, Shiga, Japan) 
with Rotor-Gene 3000 (Corbett Research, Sydney, Australia). 
The relative gene copy number was calculated by the 
concentration-CT standard curve method and normalized 
using the average expression of GAPDH.
Western blot analysis
In order to examine the expression of caspase-3, bax, 
bcl-2, NF-κB, and survivin, we next performed Western 
blot analysis on whole cell protein extracted from cells 
treated for 48 hours as described previously. In brief, 
total protein was isolated on ice and subjected to 10% 
sodium dodecylsulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) gels using modified radio immunoprecipitation 
assay buffer, and transferred to a polyvinylidene difluoride 
membrane (Bio-Rad). Western blotting was performed with 
a 1:1000–1200 dilutions of monoclonal antibodies against 
either anti-human caspase-3, bax, bcl-2, NF-κB, surviving, 
or β-actin anti-body in 5% nonfat dry milk, and then with 
horseradish peroxidase-conjugated goat anti-rabbit (1:5000) 
as a secondary antibody. The band was detected by using an 
enhanced chemiluminescence detection system (Amersham, 
Buckinghamshire, UK).
statistical analysis
All data were presented as means ± standard deviation in 
triplicate and analyzed using SPSS software (v. 15.0; SPSS 
Inc., Chicago, IL). The difference among various groups was 
analyzed by ANOVA test, and P values of less than 0.05 
were considered significant.
Result
synergistic effect on cytotoxicity 
of K562 cells
The MTT assay revealed that GA inhibited the survival of K562 
cells in a dose- and time-dependent manner and the IC50 was 
1.13 mg/L (Figure 1). Furthermore, it was observed that the 
addition of MNPs-Fe3O4 did enchance the inhibition of GA to 
K562 cells, and 10 mg/L MNPs-Fe3O4 reduced the IC50 value of 
GA to 0.72 mg/L (P  0.05) (Figure 2), suggesting MNPs-Fe3O4 
with GA have a synergistic effect on K562 cells.
synergistic effect on apoptosis 
of K562 cells
Only (7.1% ± 3.23%) apoptosis of K562 cells were observed 
under 10 mg/L MNPs-Fe3O4, there was no significant changes 
compared to the control group (6.1% ± 1.67%) (P  0.05). 
The apoptosis of K562 cells induced by 0.6 mg/L GA for 
48 hours was (35.2% ± 3.37%) (P  0.05), while com-
bination of  GA with 10 mg/L MNPs-Fe3O4 increased to 
(48.7% ± 1.47%) (P  0.05) (Figure 3), which indicated 
that MNPs-Fe3O4 could enhance GA-induced apoptosis.
Morphological changes of K562 Cells
The morphological changes of K562 cells by optical micro-
scope were shown in Figure 4. K562 cells in control group 
displayed normal, healthy shape demonstrated by the clear 
skeletons (Figure 4A); After treatment with 0.6 mg/L GA and 
10 mg/L MNPs-Fe3O4 for 48 hours, typical cytomorphologi-
cal features of apoptosis in K562 cells were evident, such 
as cell shrinkage, chromatin condensation, margination, and 
presence of apoptotic bodies (Figure 4B); While large dose 
of GA led K562 cells to necrosis (Figure 4C).
Under the fluorescence microscope, the nucleolus changes 
of K562 cells were observed (Figure 5). K562 cells in control 
group were stained equably blue fluorescence, indicating that 
the chromatin equably distributed in nucleolus (Figure 5A), 
but 0.6 mg/L GA led a few K562 cells to display chromatin 
condensation and nucleolus pyknosis (Figure 5B). After 
incubated with 0.6 mg/L GA and 10 mg/L MNPs-Fe3O4 for 
Figure 1 effect of the different concentrations of gambogic acid (gA) on growth 
inhibition ratio of K562 cells by MTT assay.
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48 hours, the cells emitting bright fluorescence increased 
and displayed the typical phenomena of apoptosis including 
chromatin condensation, nucleolus pyknosis, and nuclear 
fragmentation (Figure 5C).
Transcription of caspase-3, bax, bcl-2, 
NF-κB and survivin by QPCR
10 mg/L MNPs-Fe3O4 could not influence the expression 
of caspase-3, bax, bcl-2, NF-κB, and survivin mRNA, but 
the synergia of 0.6 mg/L GA and 10 mg/L MNPs-Fe3O4 for 
48 hours could dramatically upregulate the transcription 
of caspase-3 and bax mRNA in K562 cells (P  0.05), 
surpassing the effects of 0.6 mg/L GA alone (Figure 6C) 
(P  0.05). Meanwhile, the co-treatment of agents men-
tioned above for 48 hours seemed to induce degradation 
of bcl-2, NF-κB, and survivin mRNA on K562 cells 
(P  0.05), also surpassing the effects of GA (0.6 mg/L) 
alone (P  0.05).
expression of caspase-3, bax, bcl-2, NF-κB, 
and survivin protein by Western blot
Based on computer-assisted image analysis, it seems that 
caspase-3, bax, bcl-2, NF-κB, and survivin proteins in K562 
cells treated with 10 mg/L MNPs-Fe3O4 had no significant 
changes when compared to control group (P  0.05). How-
ever, the level of caspase-3 and bax proteins in K562 cells 
treated with 0.6 mg/L GA dramatically elevated, compared to 
control group (P  0.05) (Figure 7). Furthermore, these two 
kinds of proteins, whose genes were upregulated in 0.6 mg/L 
GA and 10 mg/L MNPs-Fe3O4 group in K562 cells (Fig-
ure 6),were more than those of 0.6 mg/L GA alone (P  0.05). 
Reversely, compared with the control group, the level of 
other three proteins in cells after co-treatment as described 
previously was lower than those of 0.6 mg/L GA alone 
(P  0.05) (Figure 7).
Discussion
Although many chemotherapy drugs are used clinically, 
the overall survival of leukemia patients is still unsatis-
factory. The majority of chemotherapy medicines have 
serious adverse effects in addition to their clinical effects. 
Patients find these side effects hard to tolerate, which 
often causes chemotherapy failure. GA differs from other 
anticancer drugs as it is an apoptotic inducer from tradi-
tional Chinese medicine. It can induce tumor cell death 
selectively without toxicity to normal tissue, which offers 
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a unique prospect in the development of new antitumor 
medicine.4,19 Apoptosis is an important metabolic step in 
regulating the number of cells and their growth. If apop-
tosis is blocked, the metabolism will become disordered 
and tumors will develop and grow.20 Most anticancer 
agents exert their anticancer effects by inducing apopto-
sis.21 Recently, MNPs-Fe3O4 are widely used for targeted-
drug carriers to enhance the efficiency of anticancer 
drug delivery based on the ability of target-orientation 
and sustained-release properties.18 Our previous studies 
have demonstrated the synergistic effect of MNPs-Fe3O4 
with anticancer drug on the intracellular accumulation in 
leukemia cells.22–28 Thus, in the present study, we wanted 
to demonstrate the potential synergistic effects of MNPs-
Fe3O4 and GA on apoptosis in leukemia cells.
Data from our cytotoxicity assay showed that MNPs-Fe3O4 
enhanced the toxicity of GA in K562 cells and the addition 
of MNPs-Fe3O4 decreased the IC50 of GA in K562 cells. 
This phenomenon is consistent with our previous studies 
that reported that less than 20 mg/L of MNPs-Fe3O4 did 
not influence the multiplication of K562 cells.26 We also 
investigated the synergistic effects of GA with MNPs-Fe3O4 
on the apoptosis of K562 cells. The addition of 10 mg/L 
MNPs-Fe3O4 caused the apoptotic percentage of K562 cells 
induced by 0.6 mg/L GA for 48 hours to increase by 14.4%. 
Our outcomes clearly indicate that a MNPs-Fe3O4-drug 
delivery system can decrease the IC50 of GA and enhance 
apoptosis in leukemia cells.
In order to check whether the effects of MNPs-Fe3O4 
combining with a small dose of chemotherapeutic agent was 
Figure 3 effect of MNPs-Fe3O4 on gA-induced apoptosis in K562 cells for 48 hours. A) Control; B) Incubated with 10 mg/L MNPs-Fe3O4; C) Incubated with 0.6 mg/L gA; 
D) Incubated with 0.6 mg/L gA and 10 mg/L MNPs-Fe3O4.
Abbreviations: MNPs-Fe3O4, magnetic nanoparticles of Fe3O4; gA, gambogic acid.
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different from the effects of a large dose of chemotherapeutic 
agent on K562 cells,28 we demonstrated that the K562 
cells in 0.6 mg/L GA and 10 mg/L MNPs-Fe3O4 group 
for 48 hours showed a typical morphological features of 
apoptosis under the optical microscope, while 6 mg/L GA led 
cells to necrosis. This effect supports our previous assump-
tion. Meanwhile, the cells incubated with 0.6 mg/L GA 
and 10 mg/L MNPs-Fe3O4 displayed the typical apoptosis 
under the fluorescence microscope, compared with that of 
0.6 mg/L alone. These results suggest that a combination of 
MNPs-Fe3O4 and GA could be a feasible candidate in the 
development of anticancer drugs.
Apoptosis is the consequence of a series of precisely 
regulated events that are frequently altered in tumor cells. In 
general, the sequence of events has been broadly categorized 
into two pathways: the extrinsic pathway, which involves 
the activation of the tumor necrosis factor (TNF)/Fas death 
receptor family and the intrinsic pathway, which involves the 
mitochondria. In both pathways, an apoptotic death stimulus 
results in the activation of caspases, the major execution-
ers of this process, either directly or via activation of the 
mitochondrial death program.10,29–31 It is well known that 
caspase-3 is the most characterized effector caspase, and its 
activation leads to the final stages of cellular death by pro-
teolytic dismantling of a large variety of cellular components 
on one hand, and activation of proapoptotic factors on the 
other hand.29–31 Our study showed that GA combined with 
MNPs-Fe3O4 dramatically upregulated the transcription and 
expression of caspase-3 in K562 cells. This result supports 
the promotion of GA-induced apoptosis by MNPs-Fe3O4 was 
related to the level of genes and proteins expression.
In tumor cells, apoptosis can be induced either by acti-
vation of molecules upstream of apoptosis signaling or 
by inhibition of antiapoptotic factors. Survivin, a member 
of the inhibitor of apoptosis protein (IAP) family, is 
overexpressed in virtually every human cancer. In several 
tumor cell lines, the presence of survivin correlates with 
resistance to apoptosis and is associated with increased 
malignancy.14,32,33 Previous in vitro studies showed that 
inhibition of survivin restored or enhanced the cytotoxicity 
of chemoreagents,34,35 and animal studies showed a superb 
efficacy against xenografts using an adenoviral strategy 
targeted to survivin.36,37 At present, survivin is validated as 
a cancer therapeutic target.38 Our data showed that the expres-
sion of antiapoptotic genes such as bcl-2, survivin of K562 
Figure 5 Nucleolus morphological changes of K562 cells after different treatment for 48 hours under fluorescence microscope (400x, DAPI staining). A) Control; B) Incubated 
with 0.6 mg/L gA; C) Incubated with 0.6 mg/L gA and 10 mg/L MNPs-Fe3O4.
Abbreviations: MNPs-Fe3O4, magnetic nanoparticles of Fe3O4; gA, gambogic acid.
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results showed, GA combined with MNPs-Fe3O4 induced 
the degradation of NF-κB genes and proteins in K562 cells. 
We presumed that they inhibited the activation of NF-κB 
and worked through downregulated NF-κB-regulated gene 
products involved in antiapoptosis such as IAP1, IAP2, bcl-2, 
Bcl-xL, and TRAF1.2
Kasibhatla and colleagues10 reported an undiscovered link 
between transferrin receptor (TfR) and the rapid activation of 
apoptosis. GA binding to TfR induced a unique signal leading 
to rapid apoptosis of tumor cells. TfR, the molecular target 
for GA, was significantly overexpressed in different types of 
cancers. However, GA bound to the TfR independent of the 
transferring-binding site. Binding of GA to TfR activated 
the apoptosis cascade rapidly by using caspase-8 and the 
mitochondrial pathway. They also demonstrated that GA 
and transferrin bound to independent sites on the receptor 
and it appeared that GA was not competed by transferring. 
Yong Yang and colleagues19 proved that GA not only banded 
to transmembrane protein TfR, but also permeated the cell 
membrane and distributed in the cell matrix. Apart from 
the “extrinsic” pathway, they hypothesized that the intrinsic 
mitochondrial pathway for the activation of caspases might 
also be involved in GA-induced apoptosis. In our research, 
GA combined with MNPs-Fe3O4 induced apoptosis not only 
through influencing the regulatory factors in the intrinsic 
mitochondrial pathway such as bax and bcl-2, but also 
through regulating the transcription factor NF-κB involved 
in the extrinsic death receptor signaling pathway in apopto-
sis. We hypothesized that both pathways might be involved 
in apoptosis induced by the combination of MNPs-Fe3O4 
with GA. Besides, in our study, a significant change was 
observed in apoptosis of K562 cells after GA combined with 
MNPs-Fe3O4, which obviously surpassed the effects of GA 
alone. We supposed that in addition to binding to TfR and 
stimulating a unique signal of rapid apoptosis, GA loaded on 
MNPs-Fe3O4 also permeated the cell membrane through bind-
ing to the transferring-binding site of TfR and the endocytosis, 
which were potential routes into cells for MNPs-Fe3O4. Our 
assumption should be proven by future research.
In conclusion, our study demonstrates for the first time 
that MNPs-Fe3O4 can promote apoptosis induction of GA 
in vitro in leukemic cells, and the synergistic effect of that 
composite on apoptosis induction may owe to the regulation 
of various proliferative and antiapoptotic gene products, 
including caspase-3, bax, bcl-2, NF-κB, and survivin. Thus, 
it may be possible that a combination of MNPs-Fe3O4 and 
GA may be a sufficient and less toxic method in leukemia 
therapy.
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Figure 7 expression of caspase-3, bax, bcl-2, NF-κB, and survivin protein in K562 
cells by western blot after treatment of gA and/or MNPs-Fe3O4 for 48 hours. Line 1: 
Control; Line 2: Incubated with 10 mg/L MNPs-Fe3O4; Line 3: Incubated with 0.6 mg/L 
gA; Line 4: Incubated with 0.6 mg/L gA and 10 mg/L MNPs-Fe3O4.
Abbreviations: MNPs-Fe3O4, magnetic nanoparticles of Fe3O4; gA, gambogic acid; 
NF-κB, nuclear factor-kappaB.
cells were significantly downregulated after co-treatment of 
GA with MNPs-Fe3O4, whereas the expression of bax was 
upregulated. Bax and bcl-2 both belong to the bcl-2 family.39 
Overexpression of Bax has been shown to accelerate cell 
death,40,41 while overexpression of antiapoptotic proteins such 
as bcl-2 represses the death function of bax.42 Thus, the ratio 
of bcl-2/bax might be a critical factor of a cell’s threshold 
for undergoing apoptosis.43 Although bcl-2 and survivin are 
both apoptosis inhibitors, they work through different path-
ways in the regulation of cell apoptosis. The antiapoptotic 
protein bcl-2 mainly inhibits the mitochondrial pathways,44,45 
while survivin directly blocks the processing and activation 
of effector caspase-3 and caspase-7, which commonly acts 
downstream of both apoptosis signaling pathways,46 which 
suggests that MNPs-Fe3O4 loaded with GA induced cell 
apoptosis through various pathways.
NF-κB is a transcription factor,47 which regulates the 
expression of several genes whose products are involved 
in tumorigenesis. Apoptosis and tumorigenesis are known 
to be regulated by NF-κB-regulated gene products.48 The 
transcription factor NF-κB involves the extrinsic death 
receptor signaling pathway of apoptosis. Suppression of 
NF-κB activation promotes TNF-induced apoptosis.49 As our International Journal of Nanomedicine 2009:4 258
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